Places

Our Research & Development capabilities are located in Japan and USA.

• 

  Tokyo, Japan - TTI Ellebeau, Inc.

  TTI Ellebeau, Inc., a subsidiary of Transcu focuses on research and development, business development and manufacturing of pharmaceutical and cosmeceutical products and exploration of new technology. Its role includes:

  • Selection of active ingredients for transdermal drug delivery for cosmetic use
  • Formulation development
  • Analytical methods development & validation
  • In vitro and in vivo feasibility studies
  • Investigational product GMP facility
• 

  Seattle, Washington USA – Dharma Therapeutics, Inc.

  Dharma Therapeutics, Inc. ("Dharma"), a subsidiary of Transcu, is a drug delivery company based in Seattle, Washington. It focuses on the clinical development of our pharmaceutical products. Its role encompasses the following:

  • Formulation development and analysis with HPLC, LC-M/S
  • Medical material selection and optimization
  • cGMP facility for Clinicial Trials
  • Quality control and quality assurance for mass production
  • FDA regulatory management

• Academic and Research Institutions

  As part of its R&D commitment, Transcu participates in sponsored joint research program with leading academic and research institutions listed below to gain additional external resource. These collaborations lend expertise to Transcu that would not be cost effective for us to develop internally.

  • Tokyo Metropolitan University <http://www.metro-u.ac.jp/>
  • Hokkaido University < http://www.hokudai.ac.jp/>
  • Tokushima University < http://www.tokushima-u.ac.jp/>
  • IDRI (International Disease Research Institute) < http://www.idri.org/>>